Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018, Article ID 7209872, 11 pages
https://doi.org/10.1155/2018/7209872
Clinical Study

Serum Levels of Interleukin-13 Increase in Subjects with Insulin Resistance but Do Not Correlate with Markers of Low-Grade Systemic Inflammation

1Unit of Experimental Medicine, School of Medicine, National University of Mexico, General Hospital of Mexico “Dr. Eduardo Liceaga”, 06726 Mexico City, Mexico
2Departamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
3Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, 06726 Mexico City, Mexico

Correspondence should be addressed to Galileo Escobedo; moc.nsm@godebocseg

Received 1 September 2017; Revised 7 December 2017; Accepted 18 December 2017; Published 21 February 2018

Academic Editor: Bernard Portha

Copyright © 2018 Camilo P. Martínez-Reyes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Meza, T. Barrientos-Gutierrez, R. Rojas-Martinez et al., “Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates,” Preventive Medicine, vol. 81, pp. 445–450, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. E. K. Spanakis and S. H. Golden, “Race/ethnic difference in diabetes and diabetic complications,” Current Diabetes Reports, vol. 13, no. 6, pp. 814–823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Esser, S. Legrand-Poels, J. Piette, A. J. Scheen, and N. Paquot, “Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 105, no. 2, pp. 141–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Mahalle, M. V. Kulkarni, S. S. Naik, and M. K. Garg, “Association of dietary factors with insulin resistance and inflammatory markers in subjects with diabetes mellitus and coronary artery disease in Indian population,” Journal of Diabetes and its Complications, vol. 28, no. 4, pp. 536–541, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. V. Shah, V. L. Murthy, S. A. Abbasi et al., “Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study,” JACC: Cardiovascular Imaging, vol. 7, no. 12, pp. 1221–1235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. U. Amano, J. L. Cohen, P. Vangala et al., “Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation,” Cell Metabolism, vol. 19, no. 1, pp. 162–171, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Torres-Castro, U. D. Arroyo-Camarena, C. P. Martinez-Reyes et al., “Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose,” Immunology Letters, vol. 176, pp. 81–89, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Leon-Cabrera, Y. Arana-Lechuga, E. Esqueda-Leon et al., “Reduced systemic levels of IL-10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans,” Mediators of Inflammation, vol. 2015, Article ID 493409, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Tzanavari, P. Giannogonas, and K. P. Karalis, “TNF-α and obesity,” Current Directions in Autoimmunity, vol. 11, pp. 145–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kwon and J. E. Pessin, “Adipokines mediate inflammation and insulin resistance,” Frontiers in Endocrinology, vol. 4, p. 71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Saghizadeh, J. M. Ong, W. T. Garvey, R. R. Henry, and P. A. Kern, “The expression of TNF alpha by human muscle. Relationship to insulin resistance,” The Journal of Clinical Investigation, vol. 97, no. 4, pp. 1111–1116, 1996. View at Publisher · View at Google Scholar
  12. P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J. R. Zierath, and B. K. Pedersen, “Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation,” Diabetes, vol. 54, no. 10, pp. 2939–2945, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a phenotypic switch in adipose tissue macrophage polarization,” The Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Chen, R. Chen, H. Wang, and F. Liang, “Mechanisms linking inflammation to insulin resistance,” International Journal of Endocrinology, vol. 2015, Article ID 508409, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Oeser, C. Schwartz, and D. Voehringer, “Conditional IL-4/IL-13-deficient mice reveal a critical role of innate immune cells for protective immunity against gastrointestinal helminths,” Mucosal Immunology, vol. 8, no. 3, pp. 672–682, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Agrawal and R. G. Townley, “Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma,” Expert Opinion on Biological Therapy, vol. 14, no. 2, pp. 165–181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Kwon, S. Laurent, Y. Tang, H. Zong, P. Vemulapalli, and J. E. Pessin, “Adipocyte-specific IKKβ signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine feedback pathway,” Cell Reports, vol. 9, no. 5, pp. 1574–1583, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Darkhal, M. Gao, Y. Ma, and D. Liu, “Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice,” International Journal of Obesity, vol. 39, no. 8, pp. 1292–1299, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Rutti, C. Howald, C. Arous, E. Dermitzakis, P. A. Halban, and K. Bouzakri, “IL-13 improves beta-cell survival and protects against IL-1beta-induced beta-cell death,” Molecular Metabolism, vol. 5, no. 2, pp. 122–131, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Q. Jiang, N. Franck, B. Egan et al., “Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7,” American Journal of Physiology Endocrinology and Metabolism, vol. 305, no. 11, pp. E1359–E1366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Q. Qu, Q. Li, A. R. Rentfro, S. P. Fisher-Hoch, and J. B. McCormick, “The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning,” PLoS One, vol. 6, no. 6, article e21041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Zhu, “T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production,” Cytokine, vol. 75, no. 1, pp. 14–24, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Madhumitha, V. Mohan, M. Deepa, S. Babu, and V. Aravindhan, “Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease,” Cardiovascular Diabetology, vol. 13, no. 1, p. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. T. K. Nestvold, E. W. Nielsen, J. K. Ludviksen, H. Fure, A. Landsem, and K. T. Lappegard, “Lifestyle changes followed by bariatric surgery lower inflammatory markers and the cardiovascular risk factors C3 and C4,” Metabolic Syndrome and Related Disorders, vol. 13, no. 1, pp. 29–35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. D. O. Minchenko, V. V. Davydov, O. A. Budreiko et al., “The expression of CCN2, IQSEC, RSPO1, DNAJC15, RIPK2, IL13RA2, IRS1, and IRS2 genes in blood of obese boys with insulin resistance,” Fiziologicheskiĭ Zhurnal, vol. 61, no. 1, pp. 10–18, 2015. View at Publisher · View at Google Scholar
  26. K. J. Stanya, D. Jacobi, S. Liu et al., “Direct control of hepatic glucose production by interleukin-13 in mice,” The Journal of Clinical Investigation, vol. 123, no. 1, pp. 261–271, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Nishimura, T. Inoue, T. Nitto, T. Morooka, and K. Node, “Increased interleukin-13 levels in patients with chronic heart failure,” International Journal of Cardiology, vol. 131, no. 3, pp. 421–423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. U. Amit, D. Kain, A. Wagner et al., “New role for interleukin-13 receptor α1 in myocardial homeostasis and heart failure,” Journal of the American Heart Association, vol. 6, no. 5, article e005108, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. S. A. Westphal, “Obesity, abdominal obesity, and insulin resistance,” Clinical Cornerstone, vol. 9, no. 1, pp. 23–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. C. Berry, D. Stenesen, D. Zeve, and J. M. Graff, “The developmental origins of adipose tissue,” Development, vol. 140, no. 19, pp. 3939–3949, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. F. M. Schmidt, J. Weschenfelder, C. Sander et al., “Inflammatory cytokines in general and central obesity and modulating effects of physical activity,” PLoS One, vol. 10, no. 3, article e0121971, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Nehete, E. R. Magden, B. Nehete, P. W. Hanley, and C. R. Abee, “Obesity related alterations in plasma cytokines and metabolic hormones in chimpanzees,” International Journal of Inflammation, vol. 2014, Article ID 856749, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Marks, “Temporary removal: rebirth of the incretin concept; its conception and early development,” Peptides, 2017, In press. View at Publisher · View at Google Scholar · View at Scopus
  34. P. D. Mitchell, B. M. Salter, J. P. Oliveria et al., “Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation,” Clinical & Experimental Allergy, vol. 47, no. 3, pp. 331–338, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Lu, Y. Xu, Z. Su, and H. Xu, “Enhanced ILC2 activity contributes to metabolic syndrome multicomponent aggregation state in patients with type 2 diabetic nephropathy,” Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, vol. 33, no. 6, pp. 820–825, 2017. View at Google Scholar
  36. L. H. Tangeras, M. Austdal, R. B. Skrastad et al., “Distinct first trimester cytokine profiles for gestational hypertension and preeclampsia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 11, pp. 2478–2485, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Surendar, V. Mohan, M. M. Rao, S. Babu, and V. Aravindhan, “Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103),” Diabetes Technology & Therapeutics, vol. 13, no. 4, pp. 477–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. H. Tsao, M. Y. Shiau, P. H. Chuang, Y. H. Chang, and J. Hwang, “Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis,” Journal of Lipid Research, vol. 55, no. 3, pp. 385–397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M. M. van Greevenbroek, C. G. Schalkwijk, and C. D. Stehouwer, “Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences,” The Netherlands Journal of Medicine, vol. 71, no. 4, pp. 174–187, 2013. View at Google Scholar
  40. M. Chalubinski, E. Luczak, K. Wojdan, P. Gorzelak-Pabis, and M. Broncel, “Innate lymphoid cells type 2 - emerging immune regulators of obesity and atherosclerosis,” Immunology Letters, vol. 179, pp. 43–46, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. S. K. Chang, A. C. Kohlgruber, F. Mizoguchi et al., “Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes,” The Journal of Clinical Investigation, vol. 127, no. 9, pp. 3300–3312, 2017. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Pilatz, C. Hudemann, J. Wolf et al., “Metabolic syndrome and the seminal cytokine network in morbidly obese males,” Andrology, vol. 5, no. 1, pp. 23–30, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. J. P. Sikora, W. Kuzanski, and E. Andrzejewska, “Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children,” Medical Science Monitor, vol. 15, no. 1, pp. CR26–CR31, 2009. View at Google Scholar
  44. I. Matia-García, J. Muñoz-Valle, Z. Reyes-Castillo et al., “Correlation between cytokine profile and metabolic abnormalities in young subjects,” International Journal of Clinical and Experimental Medicine, vol. 9, no. 8, pp. 16596–16604, 2016. View at Google Scholar